IL129178A0 - Induction of nerve generation - Google Patents
Induction of nerve generationInfo
- Publication number
- IL129178A0 IL129178A0 IL12917899A IL12917899A IL129178A0 IL 129178 A0 IL129178 A0 IL 129178A0 IL 12917899 A IL12917899 A IL 12917899A IL 12917899 A IL12917899 A IL 12917899A IL 129178 A0 IL129178 A0 IL 129178A0
- Authority
- IL
- Israel
- Prior art keywords
- cgs
- nerve
- resulting
- activities
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
- A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Psychiatry (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Priority Applications (17)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL12917899A IL129178A0 (en) | 1999-03-25 | 1999-03-25 | Induction of nerve generation |
DE60018554T DE60018554T2 (de) | 1999-03-25 | 2000-03-24 | Arzneimittel zur förderung der neuronalen zelldifferenzierung, die cyclische glycerophosphate und deren analoga enthalten |
RU2001128743/15A RU2247557C2 (ru) | 1999-03-25 | 2000-03-24 | Фармацевтические композиции, включающие циклические глицерофосфаты и их аналоги, для активации дифференцировки нервных клеток |
NZ514525A NZ514525A (en) | 1999-03-25 | 2000-03-24 | Pharmaceutical compositions comprising cyclic glycerophosphates and analogs thereof for promoting neural cell differentiation |
CA002368597A CA2368597A1 (en) | 1999-03-25 | 2000-03-24 | Pharmaceutical compositions comprising cyclic glycerophosphates and analogs thereof for promoting neural cell differentiation |
BR0009296-7A BR0009296A (pt) | 1999-03-25 | 2000-03-24 | Composição farmacêutica, processos para induzirpromoção de diferenciação de células neurais decélulas-alvo, para promover atividade neural emum indivìduo, e para prevenção ou tratamento dedistúrbios e doenças que podem ser prevenidos outratados por meio de promoção de diferenciaçãode células neurais e/ou de atividade neural, e, usode um composto |
MXPA01009650A MXPA01009650A (es) | 1999-03-25 | 2000-03-24 | Composiciones farmaceuticas que comprenden glicerofosfatos ciclicos y analogos de los mismos para estimular diferenciacion celular neuronal. |
AT00912877T ATE290385T1 (de) | 1999-03-25 | 2000-03-24 | Arzneimittel zur förderung der neuronalen zelldifferenzierung, die cyclische glycerophosphate und deren analoga enthalten |
JP2000607616A JP2002540146A (ja) | 1999-03-25 | 2000-03-24 | 神経細胞分化を促進するための環状グリセロリン酸とその類似体を含む医薬組成物 |
KR1020017012158A KR20010112364A (ko) | 1999-03-25 | 2000-03-24 | 신경 세포 분화를 촉진시키기 위한 환상 글리세로인산염및 그의 유사체를 포함하는 제약 조성물 |
EP00912877A EP1162959B1 (en) | 1999-03-25 | 2000-03-24 | Pharmaceutical compositions comprising cyclic glycerophosphates and analogs thereof for promoting neural cell differentiation |
IL14530000A IL145300A0 (en) | 1999-03-25 | 2000-03-24 | Pharmaceutical compositions comprising cyclic glycerophosphates and analogs thereof for promoting neural cell differentiation |
AU34517/00A AU768911B2 (en) | 1999-03-25 | 2000-03-24 | Pharmaceutical compositions comprising cyclic glycerophosphates and analogs thereof for promoting neural cell differentiation |
US09/936,922 US6914056B1 (en) | 1999-03-25 | 2000-03-24 | Pharmaceutical compositions comprising cyclic glycerophosphates and analogs thereof for promoting neural cell differentiation |
CN00806738A CN1348375A (zh) | 1999-03-25 | 2000-03-24 | 用于促进神经细胞分化的含有环状甘油磷酸酯及其类似物的药物组合物 |
PCT/IL2000/000185 WO2000057865A2 (en) | 1999-03-25 | 2000-03-24 | Pharmaceutical compositions comprising cyclic glycerophosphates and analogs thereof for promoting neural cell differentiation |
HK02101620.4A HK1042038A1 (zh) | 1999-03-25 | 2002-03-04 | 用於促進神經細胞分化的含有環狀甘油磷酯及其類似物的藥物組合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL12917899A IL129178A0 (en) | 1999-03-25 | 1999-03-25 | Induction of nerve generation |
Publications (1)
Publication Number | Publication Date |
---|---|
IL129178A0 true IL129178A0 (en) | 2000-02-17 |
Family
ID=11072645
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL12917899A IL129178A0 (en) | 1999-03-25 | 1999-03-25 | Induction of nerve generation |
Country Status (16)
Country | Link |
---|---|
US (1) | US6914056B1 (ja) |
EP (1) | EP1162959B1 (ja) |
JP (1) | JP2002540146A (ja) |
KR (1) | KR20010112364A (ja) |
CN (1) | CN1348375A (ja) |
AT (1) | ATE290385T1 (ja) |
AU (1) | AU768911B2 (ja) |
BR (1) | BR0009296A (ja) |
CA (1) | CA2368597A1 (ja) |
DE (1) | DE60018554T2 (ja) |
HK (1) | HK1042038A1 (ja) |
IL (1) | IL129178A0 (ja) |
MX (1) | MXPA01009650A (ja) |
NZ (1) | NZ514525A (ja) |
RU (1) | RU2247557C2 (ja) |
WO (1) | WO2000057865A2 (ja) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69912808T2 (de) | 1999-12-08 | 2004-09-30 | Centre National De La Recherche Scientifique (C.N.R.S.) | Verwendung von Hymenialdisin und dessen Derivaten zur Herstellung therapeutischer Mittel |
JP4815063B2 (ja) * | 2001-04-13 | 2011-11-16 | きみ子 室伏 | 環状ホスファチジン酸を含むグリア細胞の増殖、分化及び/又は生存の促進のための薬剤 |
JP4836345B2 (ja) * | 2001-04-13 | 2011-12-14 | きみ子 室伏 | 環状ホスファチジン酸誘導体を含む神経細胞の生存促進剤 |
IL148668A0 (en) * | 2002-03-13 | 2002-09-12 | Yeda Res & Dev | Derivatives of 1,3-cyclic propandiol phosphate and their action in differentiation therapy |
IL148665A0 (en) * | 2002-03-13 | 2002-09-12 | Yeda Res & Dev | Derivatives of 1,3-cyclic propandiol phate and their action as cell stimulants |
AU2003220521A1 (en) * | 2002-03-27 | 2003-10-13 | Smithkline Beecham Corporation | Methods of treatment with lxr modulators |
JP4162927B2 (ja) | 2002-06-11 | 2008-10-08 | きみ子 室伏 | カルバ環状ホスファチジン酸誘導体 |
US8101552B2 (en) * | 2005-03-14 | 2012-01-24 | Yeda Research And Development Company Ltd. | Cyclic phosphates as plant growth regulators |
US20090093453A1 (en) * | 2006-04-26 | 2009-04-09 | Toyama Chemical Co., Ltd | Neurogenesis inducer or neuropathy therapeutic agent comprising alkyl ether derivative or salt thereof |
CA2672534A1 (en) * | 2006-12-28 | 2008-07-10 | Ochanomizu University | Analgesic agent comprising cyclic phosphatidic acid derivative |
CN102272080A (zh) * | 2009-01-09 | 2011-12-07 | 西格马-奥利奇有限公司 | β磷酸甘油的合成方法 |
JP5747263B2 (ja) * | 2009-11-26 | 2015-07-08 | 国立大学法人お茶の水女子大学 | 神経細胞死抑制剤 |
WO2014115885A1 (ja) | 2013-01-28 | 2014-07-31 | 国立大学法人お茶の水女子大学 | 脱髄疾患治療薬 |
EP2807925A1 (en) * | 2013-05-26 | 2014-12-03 | Symrise AG | Antimicrobial compositions |
AU2016366977A1 (en) * | 2015-12-08 | 2018-07-12 | Retrophin, Inc. | Cyclic phosphates and cyclic phosphoramidates for the treatment of neurologic disorders |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL63037A (en) * | 1981-06-04 | 1985-12-31 | Israel State | Dioxaphosphorinanes,their preparation and pharmaceutical and veterinary compositions containing them |
US5565439A (en) * | 1992-11-24 | 1996-10-15 | The Procter & Gamble Company | Methods of using lysophosphatidic acid for treating hyperproliferative conditions |
JPH06228169A (ja) * | 1993-02-05 | 1994-08-16 | Sagami Chem Res Center | 1−o−アシルグリセロール2,3−ホスフェートの製造法 |
JPH07149772A (ja) * | 1993-11-26 | 1995-06-13 | Sagami Chem Res Center | タンパク質リン酸化酵素cの活性促進剤 |
JPH07258278A (ja) * | 1994-03-18 | 1995-10-09 | Sagami Chem Res Center | 1−O−アシルグリセロール−2,3−ホスフェート誘導体を有効成分とするDNAポリメラーゼαの阻害剤 |
JPH0925235A (ja) * | 1995-07-13 | 1997-01-28 | Sagami Chem Res Center | 1−o−アシルグリセロール−2,3−ホスフェート誘導体を有効成分とするがん転移抑制剤 |
US6150345A (en) * | 1998-08-10 | 2000-11-21 | Regents Of The University Of California | Methods for promoting survival of myelin producing cells |
IL129179A0 (en) | 1999-03-25 | 2000-02-17 | Yeda Res & Dev | Cyclic glycerophosphates and analogs thereof |
-
1999
- 1999-03-25 IL IL12917899A patent/IL129178A0/xx unknown
-
2000
- 2000-03-24 RU RU2001128743/15A patent/RU2247557C2/ru not_active IP Right Cessation
- 2000-03-24 KR KR1020017012158A patent/KR20010112364A/ko not_active Application Discontinuation
- 2000-03-24 CA CA002368597A patent/CA2368597A1/en not_active Abandoned
- 2000-03-24 US US09/936,922 patent/US6914056B1/en not_active Expired - Fee Related
- 2000-03-24 CN CN00806738A patent/CN1348375A/zh active Pending
- 2000-03-24 DE DE60018554T patent/DE60018554T2/de not_active Expired - Fee Related
- 2000-03-24 NZ NZ514525A patent/NZ514525A/en unknown
- 2000-03-24 BR BR0009296-7A patent/BR0009296A/pt not_active IP Right Cessation
- 2000-03-24 AT AT00912877T patent/ATE290385T1/de not_active IP Right Cessation
- 2000-03-24 JP JP2000607616A patent/JP2002540146A/ja active Pending
- 2000-03-24 WO PCT/IL2000/000185 patent/WO2000057865A2/en not_active Application Discontinuation
- 2000-03-24 EP EP00912877A patent/EP1162959B1/en not_active Expired - Lifetime
- 2000-03-24 AU AU34517/00A patent/AU768911B2/en not_active Ceased
- 2000-03-24 MX MXPA01009650A patent/MXPA01009650A/es not_active Application Discontinuation
-
2002
- 2002-03-04 HK HK02101620.4A patent/HK1042038A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
JP2002540146A (ja) | 2002-11-26 |
EP1162959A2 (en) | 2001-12-19 |
HK1042038A1 (zh) | 2002-08-02 |
CA2368597A1 (en) | 2000-10-05 |
US6914056B1 (en) | 2005-07-05 |
NZ514525A (en) | 2003-10-31 |
WO2000057865A3 (en) | 2001-06-28 |
BR0009296A (pt) | 2001-12-18 |
ATE290385T1 (de) | 2005-03-15 |
RU2247557C2 (ru) | 2005-03-10 |
MXPA01009650A (es) | 2002-07-02 |
KR20010112364A (ko) | 2001-12-20 |
AU768911B2 (en) | 2004-01-08 |
DE60018554T2 (de) | 2006-04-13 |
AU3451700A (en) | 2000-10-16 |
WO2000057865A9 (en) | 2001-11-15 |
DE60018554D1 (de) | 2005-04-14 |
EP1162959B1 (en) | 2005-03-09 |
CN1348375A (zh) | 2002-05-08 |
WO2000057865A2 (en) | 2000-10-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL129178A0 (en) | Induction of nerve generation | |
IL256054A (en) | A pharmaceutical preparation containing dextromethorphan and quinidine for the treatment of nervous disorders | |
LTIP919A (en) | Drugs and process for preparing thereof | |
DE3779149D1 (de) | Galanthamin oder dessen analoge zur behandlung der alzheimerschen krankheit. | |
AU2001273574A1 (en) | Substituted 5-alkynyl pyrimidines having neurotrophic activity | |
EP0348353A3 (en) | The use of physiologically active substances for the manufacture of drugs for cerebral and neuronal diseases | |
MX9603479A (es) | Derivados de 4-amino de acido micofenolico con actividad inmunosupresora. | |
PL342078A1 (en) | Inhibition of raf kinase using symmetrical and dissymmetrical substituted dimethylureas | |
AP2002002596A0 (en) | Piperazine and piperidine derivatives. | |
ATE229806T1 (de) | Wirkstoff zur behandlung neurodegenerativer störungen | |
AU4331400A (en) | Neurotrophic substituted pyrimidines | |
ATE213411T1 (de) | Verwendung von phenserin zur herstellung von medikamenten zur behandlung von kognitiven störungen | |
EP0616032A3 (en) | Preventive or therapeutic agents for Alzheimer's disease, a seven-test method, and human tau protein kinase. | |
ATE444077T1 (de) | Präventiva und therapeutika für mit demyelinisierung-assozierten erkrankungen | |
EP1032556A4 (en) | PHARMACEUTICALLY EFFECTIVE COMPOUNDS AND METHODS OF THEIR APPLICATION | |
DE69636934D1 (de) | Verwendung von aromatischen oder verzweigten aminosäuren zur behandlung von bewegungsstörungen | |
AP9901473A0 (en) | Use of benzopyranols to treat neurological disorders. | |
PL376149A1 (en) | Piperazine and piperidine derivatives for treatment of neurological diseases | |
TW427986B (en) | 4-amino 6-substituted mycophenolic acid and derivatives | |
BR0314541A (pt) | Tratamento de demência e doença de parkinson | |
EP0457671A3 (en) | Dipyridamide for the treatment of diseases of the central or peripheral nervous system | |
WO2005009359A3 (en) | Agents, compositions and methods for enhancing neurological function | |
ATE369143T1 (de) | Verwendung von ngali nussöl zur behandlung/linderung der arthritisschmerzen und anderer ähnlichen störungen | |
WO2002076437A3 (en) | Methods for treating neurodegenerative diseases including alzheimer's | |
UA30749A (uk) | Спосіб комплексної стимулотерапії тяжких форм мовних розладів |